GeneDx to Report Fourth Quarter 2025 Financial Results on Monday, February 23, 2026
GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced it will release financial results for the fourth quarter of 2025 before the market...